This page follows insider dealings at Entheon Biomedical Corp. (formerly MPV Exploration Inc.) as filed with SEDI. The past year has been quiet: not a single insider filing for Entheon Biomedical Corp. (formerly MPV Exploration Inc.). The previous disclosure was published on 22 April 2024.
Over the whole record (from 2020), the tally stands at 4 purchases and no sales.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
13 of 13 declarations
Entheon Biomedical Corp. is a Canadian company focused on developing treatments for mental health disorders using psychedelic substances. Formerly known as MPV Exploration Inc., it is listed on the XTSE.